Gary T. Taniguchi
About Gary T. Taniguchi
Gary T. Taniguchi's Professional Title
Gary T. Taniguchi holds the position of Head of Bioanalytical Sciences. In his role, he oversees the strategic and scientific direction of bioanalytical processes related to biopharmaceutical drug development.
Gary T. Taniguchi's Experience in Biopharmaceutical Drug Development
With over 25 years of experience in the biopharmaceutical industry, Gary T. Taniguchi has extensive expertise in drug development, spanning from pre-IND to post-marketing stages. His work has covered therapeutic areas including oncology, inflammation, and rare diseases like MPS and PKU.
Gary T. Taniguchi's Expertise in CMC Analytical and Bioanalytical Sciences
Gary T. Taniguchi has strategic and scientific expertise in various aspects of CMC analytical and bioanalytical sciences. This includes analytical characterization and comparability, as well as the development of PK, immunogenicity, and PD biomarkers.
Gary T. Taniguchi's Leadership Roles in Prominent Biopharmaceutical Companies
Throughout his career, Gary T. Taniguchi has led analytical, bioanalytical, and Quality groups at several renowned biopharmaceutical companies, such as Coherus BioSciences, BioMarin, Genentech, Abbott, and PDL BioPharma/Facet Biotech (now part of AbbVie).
Gary T. Taniguchi's Contributions to Immunogenicity Strategies
Alongside other industry scientists, Gary T. Taniguchi was instrumental in writing early manuscripts on strategies to detect and characterize the immunogenicity of biotherapeutics. His work laid foundational frameworks in this critical area of biopharmaceutical research.
Gary T. Taniguchi's Educational Background
Gary T. Taniguchi received his Ph.D. in Pharmaceutical Chemistry, with a specialization in Biochemistry and Molecular Biology, from the University of California at San Francisco. This advanced education underpins his expertise in the biopharmaceutical field.